Clinically localized prostate cancer: AUA/ASTRO guideline, part I: introduction, risk assessment, staging, and risk-based management

JA Eastham, GB Auffenberg, DA Barocas… - Journal of …, 2022 - journals.lww.com
Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …

High‐intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology

X Rebillard, M Soulié, E Chartier‐Kastler… - BJU …, 2008 - Wiley Online Library
We discuss the efficacy and safety of high‐intensity focused ultrasound (HIFU) in patients
with prostate cancer, to define the best indications for HIFU in daily clinical practice as …

Technology insight: high-intensity focused ultrasound for urologic cancers

C Chaussy, S Thüroff, X Rebillard… - Nature Clinical Practice …, 2005 - nature.com
The growing interest in high-intensity focused ultrasound (HIFU) technology is mainly due to
its many potential applications as a minimally invasive therapy. It has been introduced to …

Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis

JH Hayes, DA Ollendorf, SD Pearson, MJ Barry… - Jama, 2010 - jamanetwork.com
Context In the United States, 192 000 men were diagnosed as having prostate cancer in
2009, the majority with low-risk, clinically localized disease. Treatment of these cancers is …

Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy

C Salembier, P Lavagnini, P Nickers, P Mangili… - Radiotherapy and …, 2007 - Elsevier
The aim of this paper is to supplement the GEC/ESTRO/EAU recommendations for
permanent seed implantations in prostate cancer to develop consistency in target and …

Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancer

PA Kupelian, A Mahadevan, CA Reddy, AM Reuther… - Urology, 2006 - Elsevier
OBJECTIVES: To report biochemical relapse-free survival (bRFS) after radiotherapy (RT) for
localized prostate cancer with two separate failure definitions and compare the results with …

Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up

M Ferrer, F Guedea, JF Suárez, B De Paula… - Radiotherapy and …, 2013 - Elsevier
Purpose To assess long-term quality of life (QoL) impact of treatments in localized prostate
cancer patients treated with radical prostatectomy, external beam radiotherapy or …

Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy

KA Hinnen, JJ Battermann, JGH van Roermund… - International Journal of …, 2010 - Elsevier
PURPOSE: To assess long-term biochemical and survival outcome after permanent prostate
brachytherapy (BT). METHODS AND MATERIALS: Data on 921 patients, treated with …

Injectable polypeptide micelles that form radiation crosslinked hydrogels in situ for intratumoral radiotherapy

JL Schaal, X Li, E Mastria, J Bhattacharyya… - Journal of Controlled …, 2016 - Elsevier
Abstract Intratumoral radiation therapy–'brachytherapy'–is a highly effective treatment for
solid tumors, particularly prostate cancer. Current titanium seed implants, however, are …

Brachytherapy versus prostatectomy in localized prostate cancer: results of a French multicenter prospective medico-economic study

C Buron, B Le Vu, JM Cosset, P Pommier… - International Journal of …, 2007 - Elsevier
Purpose: To prospectively compare health-related quality of life (HRQOL), patient-reported
treatment-related symptoms, and costs of iodine-125 permanent implant interstitial …